AAAAAA
Results:
1-19
|
Results: 19
Authors:
STEMMER SM
HARDAN I
RIZEL S
RAZ H
SAREL R
GRINBERGER A
ADAMOS A
KITSIOS P
INBAR M
SHAPIRA Y
BRACHA D
BRENNER H
Citation: Sm. Stemmer et al., CONSOLIDATION WITH HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT) FOR HIGH-RISK STAGE-II-III AND STAGE-IV BREAST-CANCER PATIENTS - AN UPDATE OF 211 CONSECUTIVE PATIENTS, Bone marrow transplantation, 21, 1998, pp. 216-216
Authors:
RAZ H
BRACHA D
SARELI R
PAPATRYPHONOS A
STEMMER SM
HARDAN I
Citation: H. Raz et al., CHEMOTHERAPEUTIC PRIMING AND COLLECTION OF PHILADELPHIA NEGATIVE GRAFT FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS BY A NURSING TEAM INAN AMBULATORY SETTING, Bone marrow transplantation, 21, 1998, pp. 994-994
Authors:
BROWN MS
STEMMER SM
SIMON JH
STEARS JC
JONES RB
CAGNONI PJ
SHEEDER JL
Citation: Ms. Brown et al., WHITE-MATTER DISEASE INDUCED BY HIGH-DOSE CHEMOTHERAPY - LONGITUDINAL-STUDY WITH MR-IMAGING AND PROTON SPECTROSCOPY, American journal of neuroradiology, 19(2), 1998, pp. 217-221
Authors:
STEMMER SM
CAGNONI PJ
SHPALL EJ
BEARMAN SI
MATTHES S
DUFTON C
DAY T
TAFFS S
HAMI L
MARTINEZ C
PURDY MH
ARRON J
JONES RB
Citation: Sm. Stemmer et al., HIGH-DOSE PACLITAXEL, CYCLOPHOSPHAMIDE, AND CISPLATIN WITH AUTOLOGOUSHEMATOPOIETIC PROGENITOR-CELL SUPPORT - A PHASE-I TRIAL, Journal of clinical oncology, 14(5), 1996, pp. 1463-1472
Authors:
ABRAHAM RB
HARDAN I
SEGAL E
STEMMER SM
PEREL A
Citation: Rb. Abraham et al., RESPIRATORY-FAILURE AND INTENSIVE-CARE TREATMENT IN BONE MARROW-TRANSPLANTED PATIENTS, Intensive care medicine, 22(3), 1996, pp. 269-270
Authors:
STEMMER SM
HARDAN I
Citation: Sm. Stemmer et I. Hardan, ORAL FLUCONAZOLE RATHER THAN INTRAVENOUS AMPHOTERICIN-B (AMPH-B), AS EMPIRIC ANTIFUNGAL TREATMENT FOR NEUTROPENIC FEVER IN BREAST-CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANT, Blood, 88(10), 1996, pp. 3789-3789
Authors:
STEMMER SM
SARELI R
RAZ H
HARDAN J
Citation: Sm. Stemmer et al., STANDARDIZATION AND OPTIMALIZATION OF GRAFT CONTENT AND GROWTH-FACTOR(GF) TIMING IN AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANT (APBSCT), Blood, 88(10), 1996, pp. 1619-1619
Authors:
BROWN MS
SIMON JH
STEMMER SM
STEARS JC
SCHERZINGER A
CAGNONI PJ
JONES RB
Citation: Ms. Brown et al., MR AND PROTON SPECTROSCOPY OF WHITE-MATTER DISEASE INDUCED BY HIGH-DOSE CHEMOTHERAPY WITH BONE-MARROW TRANSPLANT IN ADVANCED BREAST-CARCINOMA, American journal of neuroradiology, 16(10), 1995, pp. 2013-2020
Authors:
SCHRIER DM
STEMMER SM
JOHNSON T
KASLIWAL R
LEAR J
MATTHES S
TAFFS S
DUFTON C
GLENN SD
BUTCHKO G
CERIANI RL
ROVIRA D
BUNN P
SHPALL EJ
BEARMAN S
PURDY M
CAGNONI P
JONES RB
Citation: Dm. Schrier et al., HIGH-DOSE Y-90 MX-DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-BRE-3 ANDAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT (AHSCS) FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-I TRIAL, Cancer research, 55(23), 1995, pp. 5921-5924
Authors:
SHPALL EJ
JONES RB
BEARMAN SI
FRANKLIN WA
ARCHER PG
CURIEL T
BITTER M
CLAMAN HN
STEMMER SM
PURDY M
MYERS SE
HAMI L
TAFFS S
HEIMFELD S
HALLAGAN J
BERENSON RJ
Citation: Ej. Shpall et al., TRANSPLANTATION OF ENRICHED CD34-POSITIVE AUTOLOGOUS MARROW INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY - INFLUENCE OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITORS AND GROWTH-FACTORS ON ENGRAFTMENT, Journal of clinical oncology, 12(1), 1994, pp. 28-36
Authors:
STEMMER SM
STEARS JC
BURTON BS
JONES RB
SIMON JH
Citation: Sm. Stemmer et al., WHITE-MATTER CHANGES IN PATIENTS WITH BREAST-CANCER TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT, American journal of neuroradiology, 15(7), 1994, pp. 1267-1273
Authors:
BITTER MA
FIORITO D
CORKILL ME
HUFFER WE
STEMMER SM
SHPALL EJ
ARCHER PG
FRANKLIN WA
Citation: Ma. Bitter et al., BONE-MARROW INVOLVEMENT BY LOBULAR CARCINOMA OF THE BREAST CANNOT BE IDENTIFIED RELIABLY BY ROUTINE HISTOLOGICAL EXAMINATION ALONE, Human pathology, 25(8), 1994, pp. 781-788
Authors:
CAGNONI PJ
STEMMER SM
BEARMAN SI
SHPALL EJ
PURDY MH
MYERS S
JONES RB
Citation: Pj. Cagnoni et al., PHASE-I STUDY OF TAXOL CDDP/CYCLOPHOSPHAMIDE WITH AUTOLOGOUS HEMATOPOIETIC-CELL SUPPORT (AHCS)/, Blood, 84(10), 1994, pp. 10000486-10000486
Authors:
SHPALL EJ
STEMMER SM
HAMI L
FRANKLIN WA
SHAW L
BONNER HS
BEARMAN SI
PETERS WP
BAST RC
MCCULLOCH W
CAPIZZI R
MITCHELL E
SCHEIN PS
JONES RB
Citation: Ej. Shpall et al., AMIFOSTINE (WR-2721) SHORTENS THE ENGRAFTMENT PERIOD OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED BONE-MARROW IN BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT, Blood, 83(11), 1994, pp. 3132-3137
Authors:
SHPALL EJ
JONES RB
BEARMAN SI
STEMMER SM
PURDY MH
HEIMFELD S
BERENSON RJ
Citation: Ej. Shpall et al., POSITIVE SELECTION OF CD34+ HEMATOPOIETIC PROGENITOR CELLS FOR TRANSPLANTATION, Stem cells, 11, 1993, pp. 48-49
Authors:
SHPALL EJ
STEMMER SM
BEARMAN SI
JONES RB
Citation: Ej. Shpall et al., ROLE OF AUTOTRANSPLANTATION IN TREATMENT OF OTHER SOLID TUMORS, Hematology/oncology clinics of North America, 7(3), 1993, pp. 663-686
Authors:
JONES RB
MATTHES S
DUFTON C
BEARMAN SI
STEMMER SM
MEYERS S
SHAPALL EJ
Citation: Rb. Jones et al., PHARMACOKINETIC-PHARMACODYNAMIC INTERACTIONS OF INTENSIVE CYCLOPHOSPHAMIDE, CISPLATIN, AND BCNU IN PATIENTS WITH BREAST-CANCER, Breast cancer research and treatment, 26, 1993, pp. 190000011-190000017
Authors:
SHPALL EJ
STEMMER SM
BEARMAN SI
MYERS S
PURDY M
JONES RB
Citation: Ej. Shpall et al., NEW STRATEGIES IN MARROW PURGING FOR BREAST-CANCER PATIENTS RECEIVINGHIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Breast cancer research and treatment, 26, 1993, pp. 190000019-190000023
Authors:
BEARMAN SI
LEFKOWITZ JB
JONES RB
SHPALL EJ
STEMMER SM
Citation: Si. Bearman et al., THROMBOMODULIN INCREASES IN PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPYWITH AUTOLOGOUS PROGENITOR-CELL SUPPORT, Blood, 82(10), 1993, pp. 10000614-10000614
Risultati:
1-19
|